Intralytix joins Pitt-led P-CAPT project on Pseudomonas phage therapy

Intralytix announced a multimillion-dollar NIH P01 award for a Pitt-led CAPT-CEP project developing phage therapy for multidrug-resistant Pseudomonas aeruginosa. The collaboration includes Pitt, Walter Reed, USC, Florida International University and Intralytix.